PI3K-like kinases restrain Pim gene expression in endothelial cells

Abstract

Pim kinases contribute to tumor formation and development of lymphoma, which shows enhanced DNA replication, DNA recombination and repair. Endothelial cells^(ECs) express all the three members of Pim kinase gene family. We hypothesized that DNA repair gene would regulate Pim expression in ECs. Human umbilical vein endothelial cells (HUVECs) were isolated and maintained in M199 culture medium. The cellular distribution of Pim-3 in ECs was determined by immunofluorescent staining. The siRNA fragments were synthesized and transfected by using Lipofectamine LTX. The total cellular RNA was extracted from the cells by using Trizol reagent. cDNAs were quantified by semi-quantity PCR. The effects of LY294002 and wortmannin on RNA stability in ECs were also examined. Our data showed that LY294002 and wortmannin, phosphatidylinositol 3-kinase (PI3K) and PI3K-like kinase inhibitors, increased Pim mRNA expression in ECs without altering the mRNA stability. RNA interference (RNAi) targeting DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia telangiectasia mutated (ATM) increased mRNA expression of Pim-3 and Pim-1, respectively. Silencing of Akt decreased Pim-1 instead of Pm-2 and Pim-3 gene expression in ECs. But etoposide, a nucleoside analogue, which could activate DNA-PKcs and ATM, increased Pim expression in ECs. Our study indicates that the expression of Pim kinases is physiologically related to DNA-PKcs and ATM in ECs.

Keywords

endothelial cell / Pim-3 / phosphatidylinositol 3-kinase / DNA-dependent protein kinase catalytic subunit / ataxia telangiectasia mutated

References

[1] MiJ., DziegielewskiJ., BolestaE., et al.. Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6. PLoS One, 2009, 4(2): e4395

[2] KaufmannT., TaiL., EkertP.G., et al.. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell, 2007, 129(2): 423-433

[3] GasserS.. DNA damage response and development of targeted cancer treatments. Ann Med, 2007, 39(6): 457-464

[4] LeeS.E., MitchellR.A., ChengA., et al.. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol, 1997, 17(3): 1425-1433

[5] BaileyS.M., BrennemanM.A., HalbrookJ., et al.. The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst), 2004, 33: 225-233

[6] AndreassenP.R., D’AndreaA.D., TaniguchiT.. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev, 2004, 18(16): 1958-1963

[7] LudersJ., PatelU.K., StearnsT.. GCP-WD is a gamma-tubulin targeting factor required for centrosomal and chromatin-mediated microtubule nucleation. Nat Cell Biol, 2005, 8(2): 137-147

[8] ValdmanA., FangX., PangS.T., et al.. Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate, 2004, 60(4): 367-371

[9] HuX.F., LiJ., VandervalkS., et al.. PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest, 2009, 119(2): 362-375

[10] LiY.Y., PopivanovaB.K., NaqaiY., et al.. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res, 2006, 66(13): 6741-6747

[11] FoxC.J., HammermanP.S., CinalliR.M., et al.. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev, 2003, 17(15): 1841-1854

[12] IonovY., LeX., TunquistB.J., et al.. Pim-1 protein kinase is nuclear in Burkitt’s lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res, 2003, 23(1A): 167-178

[13] BreuerM., SlebosR., VerbeekS., et al.. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature, 1989, 340(6228): 61-63

[14] ZhangP., WangH.Q., MinX.W., et al.. Pim-3 is expressed in endothelial cells and promotes vascular tube formation. J Cell Physiol, 2009, 220(1): 82-90

[15] ZippoA., De RobertisA., BardelliM., et al.. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood, 2004, 103(12): 4536-4544

[16] ZhaoL.B., WangY.F., MinX.W., et al.. Ischemia-reperfusion injury up-regulates Pim-3 gene expression in myocardial tissue. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(6): 704-708

[17] BhattacharyaN., WangZ., DavittC., et al.. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma, 2002, 111(2): 80-95

[18] LamaliceL., Le BoeufF., HuotJ.. Endothelial cell migration during angiogenesis. Circ Res, 2007, 100(6): 782-794

[19] WuX., ShellS.M., YangZ., et al.. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res, 2006, 66(6): 2997-3005

[20] PopivanovaB.K., LiY.Y., ZhengH., et al.. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci, 2007, 98(3): 321-328

[21] MuraskiJ.A., RotaM., MisaoY., et al.. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med, 2007, 13(12): 1467-1475

[22] BachmannM., KosanC., XingP.X., et al.. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. Int J Biochem Cell Biol, 2006, 38(3): 430-443

[23] BachmannM., HennemannH., XingP.X., et al.. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem, 2004, 279(46): 48319-48328

[24] DeneenB., WelfordS.M., HoT., et al.. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol Cell Biol, 2003, 23(11): 3897-3908

[25] KrumenackerJ.S., BuckleyD.J., LeffM.A., et al.. Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine, 1998, 9(2): 163-170

[26] SturgeonC.M., KnightZ.A., ShokatK.M., et al.. Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Mol Cancer Ther, 2006, 5(4): 885-892

[27] MoroyT., GrzeschiczekA., PetzoldS., et al.. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc Natl Acad Sci USA, 1993, 90(22): 10734-10738

[28] EspejelS., MartinM., KlattP., et al.. Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice. EMBO Rep, 2004, 5(5): 503-509

[29] TrumanJ.P., RotenbergS.A., KangJ.H., et al.. PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol Ther, 2009, 8(1): 54-63

[30] WingettD., LongA., KelleherD., et al.. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J Immunol, 1996, 156(2): 549-557

[31] PeltolaK., HollmenM., MaulaS.M., et al.. Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor. Neoplasia, 2009, 117: 629-636